Production (Stage)
The Oncology Institute, Inc.
TOI
$3.02
$0.031.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.36M | -64.66M | -70.24M | -71.54M | -72.96M |
| Total Depreciation and Amortization | 6.58M | 6.29M | 6.16M | 6.28M | 6.09M |
| Total Amortization of Deferred Charges | 9.62M | 6.31M | 6.28M | 6.26M | 6.24M |
| Total Other Non-Cash Items | 8.59M | 7.47M | 11.41M | 16.05M | 19.48M |
| Change in Net Operating Assets | 23.92M | 18.06M | 11.77M | -803.00K | 4.40M |
| Cash from Operations | -15.64M | -26.54M | -34.62M | -43.75M | -36.75M |
| Capital Expenditure | -3.51M | -3.79M | -2.90M | -4.23M | -3.34M |
| Sale of Property, Plant, and Equipment | 126.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -156.00K | -156.00K | -4.46M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.00M | 50.00M | 62.64M | 61.28M | 71.42M |
| Cash from Investing | 26.62M | 46.21M | 59.59M | 56.90M | 63.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.42M | -1.20M | -3.31M | -1.73M | -3.08M |
| Issuance of Common Stock | 15.50M | 75.00K | 188.00K | 201.00K | 199.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | -125.00K | -1.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.37M | -2.37M | -1.99M | -3.97M | -2.18M |
| Cash from Financing | -7.29M | -3.49M | -5.11M | -5.62M | -6.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.68M | 16.18M | 19.87M | 7.53M | 20.81M |